425: Atlantic Coastal Acquisition Corp. II Faces Nasdaq Delisting Notice, Seeks Hearing and Extends Business Combination Deadline

Atlantic Coastal Acquisition Corp. II received a delisting notice from Nasdaq for failing to meet listing requirements and is requesting a hearing while extending the deadline for its business combination with Abpro Corporation.

Summary

• Atlantic Coastal Acquisition Corp. II (ACAB) received a delisting determination letter from Nasdaq on October 16, 2024, because it did not regain compliance with listing requirements by the October 15, 2024 deadline.
• The deficiencies include failing to maintain a minimum market value of publicly held shares of $15,000,000 and not having at least 400 unrestricted round lot holders.
• ACAB also failed to meet the minimum requirement of 750,000 publicly held shares of its listed common stock.
• ACAB intends to request a hearing before a Nasdaq Hearing Panel by October 23, 2024, which will stay the suspension/delisting action.
• The company expects to regain compliance upon closing its previously announced business combination with Abpro Corporation.
• ACAB extended the deadline to complete the business combination from October 19, 2024, to November 19, 2024.
• The Registration Statement on Form S-4 relating to the Business Combination went effective on October 18, 2024.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting notice from Nasdaq and the failure to meet listing requirements. However, the company is taking steps to address the issues, which provides a slight offset.

Positives

• ACAB is requesting a hearing before a Nasdaq Hearing Panel, which will temporarily prevent delisting.
• The company expects to regain compliance with Nasdaq listing rules upon the closing of the Business Combination with Abpro Corporation.
• The deadline for completing the business combination has been extended to November 19, 2024, providing more time to finalize the deal.
• The Registration Statement on Form S-4 relating to the Business Combination went effective on October 18, 2024.

Negatives

• ACAB received a delisting determination letter from Nasdaq.
• The company failed to maintain a minimum market value of publicly held shares of $15,000,000.
• ACAB failed to comply with Nasdaq Listing Rule 5450(a)(2), which requires a minimum of 400 unrestricted round lot holders.
• ACAB failed to meet the minimum requirement of 750,000 publicly held shares of its listed common stock.

Risks

• The business combination with Abpro may not be completed, which would leave ACAB non-compliant with Nasdaq listing rules.
• The Nasdaq Hearing Panel may not grant ACAB an extension or find in its favor, leading to delisting.
• Redemption requests by ACAB's stockholders could impact the financial viability of the business combination.
• General economic, financial, legal, political and business conditions could adversely affect the combined company.

Future Outlook

ACAB expects to regain compliance with Nasdaq listing rules upon the closing of the Business Combination with Abpro Corporation.

Management Comments

• The Company expected, and still expects, the Nasdaq Deficiencies to be cured as a result of its previously announced proposed business combination with Abpro Corporation.

Industry Context

SPACs like Atlantic Coastal Acquisition Corp. II face increasing pressure to complete business combinations within specified timeframes or risk liquidation or delisting, reflecting broader market challenges in the SPAC sector.

Comparison to Industry Standards

• Many SPACs are facing similar challenges in meeting listing requirements, particularly regarding minimum market capitalization and shareholder base, due to market volatility and increased redemption rates.
• Compared to other SPACs that have received delisting notices, ACAB is pursuing a hearing and has extended its business combination deadline, which is a common strategy to maintain its listing.
• The success of ACAB's strategy will depend on its ability to complete the merger with Abpro, similar to how other SPACs' survival hinges on successful deal closures.

Stakeholder Impact

• Shareholders face the risk of delisting, which could negatively impact the value of their investment.
• Employees may experience uncertainty due to the company's financial situation and potential changes resulting from the business combination.
• The business combination with Abpro could impact suppliers and customers of both companies.

Next Steps

• ACAB will request a hearing before the Nasdaq Hearing Panel by October 23, 2024.
• ACAB will work to complete the business combination with Abpro Corporation by November 19, 2024.

Key Dates